IP Library Granted Patent US 9,417,245
Granted Patent B2
US 9,417,245 · App. 14/619,681 · Granted Aug 16, 2016

Porphyrinic compounds for use in flow cytometry

Inventor: Jonathan S. Lindsey (Raleigh, NC)
Assignee: North Carolina State University
G01N33/582G01N21/643G01N21/6486G01N33/533G01N2021/6439Y10T436/145555
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,417,245
App. No.
14/619,681
Granted
Aug 16, 2016
Kind
B2
Abstract

The present invention provides a method of detecting (e.g., by flow cytometry) a target compound, cell or particle, wherein the target is labelled with a detectable luminescent compound. The method comprises utilizing as the detectable luminescent compound a compound comprising a porphyrinic macrocycle such as a porphyrin, chlorin, bacteriochlorin, or isobacteriochlorin. In particular embodiments, the detectable luminescent compound comprises a compound of the formula A-A′-Z—B′—B, wherein: A is a targeting group or member of a specific binding pair that specifically binds the detectable luminescent compound to the target compound, cell or particle; A′ is a linker group or covalent bond; B′ is a linker group or covalent bond; B is a water-soluble group; and Z is the porphyrinic macrocycle.

Claims (54)

1. In a method of detecting a target compound, cell or particle, wherein said target is labelled with a detectable luminescent compound, the improvement comprising utilizing as said detectable luminescent compound a compound of the formula A-A′-Z—B′—B, wherein:

A is a targeting group that specifically binds said detectable luminescent compound to said target compound, cell or particle, said targeting group selected from the group consisting of protein, peptide and antibody;

A′ is a linking group or covalent bond;

B′ is a linking group or covalent bond;

B is a water-soluble group containing at least one ionic or polar group selected from the group consisting of hydroxy, alkoxy, carboxy, nitro, cyano, amino, amido, ureido, sulfonamido, sulfinyl, sulfhydryl, silyl, S-sulfonamido, N-sulfonamido, C-carboxy, O-carboxy, C-amido, N-amido, sulfonyl, phosphono, morpholino, piperazinyl, tetrazolo, alcohol, thiol, polyethylene glycol, polyol, sulfonamide, carboxamide, hydrazide, N-hydroxycarboxamide, urea, metal chelates, carboxylate, sulfonate, phosphate, amine N-oxide, ammonium, uronic acid, carboxylic acid, sulfonic acid, amine, guanidinium, phosphoric acid, phosphonic acid, phosphatidyl choline, phosphonium, borate sulfate, and combinations thereof; and

Z is chlorin.

2. The method of claim 1 , wherein said detecting is carried out by flow cytometry.

3. The method of claim 1 , wherein said detectable luminescent compound is excited by light at an excitation wavelength band and detected by emitted light at an emission wavelength band;

and wherein said emission wavelength band has a full width at half maximum peak of not more than 100 nanometers.

4. The method of claim 3 , wherein said emission wavelength band has a full width at half maximum peak of not more than 30 nanometers.

5. The method of claim 3 , wherein

said excitation wavelength band has a peak between 350 and 900 nanometers; and

said emission wavelength band has a peak between 550 and 1000 nanometers.

6. The method of claim 3 , wherein:

said porphyrinic macrocycle is a chlorin;

said excitation wavelength band has a peak between 600 and 740 nanometers; and

said emission wavelength band has a peak between 610 and 800 nanometers.

7. The method of claim 3 , wherein:

said porphyrinic macrocycle is a chlorin;

said excitation wavelength band has a peak between 350 and 450 nanometers;

said emission wavelength band has a peak between 600 and 800 nanometers.

8. The method of claim 1 , wherein said detectable luminescent compound is excited by light at an excitation wavelength band and detected by emitted light at an emission wavelength band;

wherein said excitation wavelength band and said emission wavelength band each have peaks that are separated from one another by at least 100 nanometers;

and wherein said emission wavelength band has a full width at half maximum peak of not more than 100 nanometers.

9. The method of claim 1 , wherein said detectable luminescent compound is excited by light at an excitation wavelength band and detected by emitted light at an emission wavelength band;

wherein said excitation wavelength band and said emission wavelength band each have peaks that are separated from one another by from 10 to 100 nanometers;

and wherein said emission wavelength band has a full width at half maximum peak of not more than 25 nanometers.

10. In a method of detecting and distinguishing first and second target compounds, cells or particles, wherein said first target is labelled with a first detectable compound and said second target is labeled with a second detectable compound, the improvement comprising:

utilizing a compound comprising a first porphyrinic macrocycle as said first detectable compound and a compound comprising a second porphyrinic macrocycle as said second detectable compound;

wherein each of said first and second detectable compounds are excited at an excitation wavelength band;

wherein said first detectable compound comprises a compound of the formula A 1 -A 1′ -Z 1 —B 1 ′—B 1 , wherein:

A 1 is a targeting group that specifically binds said detectable compound to said target compound, cell or particle, said targeting group selected from the group consisting of protein, peptide, and antibody;

A 1 ′ is a linking group or covalent bond;

B 1 ′ is a linking group or covalent bond;

B 1 is a water-soluble group containing at least one ionic or polar group selected from the group consisting of hydroxy, alkoxy, carboxy, nitro, cyano, amino, amido, ureido, sulfonamido, sulfinyl, sulfhydryl, silyl, S-sulfonamido, N-sulfonamido, C-carboxy, O-carboxy, C-amido, N-amido, sulfonyl, phosphono, morpholino, piperazinyl, tetrazolo, alcohol, thiol, polyethylene glycol, polyol, sulfonamide, carboxamide, hydrazide, N-hydroxycarboxamide, urea, metal chelates, carboxylate, sulfonate, phosphate, amine N-oxide, ammonium, uronic acid, carboxylic acid, sulfonic acid, amine, guanidinium, phosphoric acid, phosphonic acid, phosphatidyl choline, phosphonium, borate, sulfate, and combinations thereof; and

Z 1 is chlorin; and

said second detectable compound comprises a compound of formula A 2 -A 2′ -Z 2 —B 2′ —B 2 , wherein:

A 2 is a targeting group that specifically binds said detectable compound to said target compound, cell or particle, said targeting group selected from the group consisting of protein, peptide and antibody:

A 2′ is a linking group or covalent bond;

B 2′ is a linking group or covalent bond;

B 2 is a water-soluble group containing at least one ionic or polar group selected from the group consisting of hydroxy, alkoxy, carboxy, nitro, cyano, amino, amido, ureido, sulfonamido, sulfinyl, sulfhydryl, silyl, S-sulfonamido, N-sulfonamido, C-carboxy, O-carboxy, C-amido, N-amido, sulfonyl, phosphono, morpholino, piperazinyl, tetrazolo, alcohol, thiol, polyethylene glycol, polyol, sulfonamide, carboxamide, hydrazide, N-hydroxycarboxamide, urea, metal chelates, carboxylate, sulfonate, phosphate, amine N-oxide, ammonium, uronic acid, carboxylic acid, sulfonic acid, amine, guanidinium, phosphoric acid, phosphonic acid, phosphatidyl choline, phosphonium, borate, sulfate, and combinations thereof; and

Z 2 is a porphyrinic macrocycle selected from the group consisting of porphyrins, chlorins, bacteriochlorins and isobacteriochlorins;

and wherein:

(i) each of said first and second detectable compounds have a different emission wavelength band, said different emission wavelength bands characterized by peaks that are separated from one another by at least 5 nanometers; or

(ii) said second compound has a lifetime at least 20 percent greater than said first compound.

11. The method of claim 10 , wherein said detecting step is carried out by flow cytometry.

12. The method of claim 10 , wherein

both of said excitation wavelength bands have a peak between 350 and 900 nanometers; and

both of said emission wavelength bands have a peak between 550 and 1000 nanometers.

13. The method of claim 10 , wherein said different emission wavelength bands are characterized by peaks that are separated from one another by at least 50 nanometers.

14. The method of claim 10 , wherein said different emission wavelength bands are characterized by peaks that are separated from one another by 10 to 50 nanometers;

and wherein each of said different emission wavelength bands have a full width at half maximum peak of not more than 30 nanometers.

15. The method of claim 1 , wherein said water soluble group is selected from the group consisting of alkoxy, carboxy, and polyethylene glycol.

16. The method of claim 10 , wherein each said water soluble group is selected from the group consisting of alkoxy, carboxy, and polyethylene glycol.

Assignments (1)
CONFIRMATORY LICENSE Recorded Jun 13, 2017
From: NORTH CAROLINA STATE UNIVERSITY RALEIGH
To: NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT
Reel/Frame 042776/0075 →
Continuity (5)
Continuation 14013745 · Aug 29, 2013
Continuation 13459464 · Apr 30, 2012
Continuation 12095423
Provisional Application 60740896 · Nov 30, 2005
Related Publication 20150153350A1 · Jun 4, 2015